rpt-3 Antibody

Basic Research Questions

• What biological role does RPT3 play in proteasome function?
  RPT3 (PSMC4) is an ATPase subunit of the 19S regulatory particle of the 26S proteasome. It facilitates substrate recognition, ATP-dependent unfolding of proteins, and gate opening of the 20S catalytic core . Methodological considerations:

  • Use co-immunoprecipitation (Co-IP) to confirm interactions with other 19S subunits (e.g., Rpt6) .

  • Monitor ATPase activity via malachite green assays in purified proteasome fractions .

• Which experimental applications are most suitable for RPT3 antibodies?
  Common applications include:

  Application	Key Validation Step	Example from Literature
  Western blot	Verify band specificity (expected ~47 kDa) with knockout controls	Rpt3-KO mice showed >90% reduction in Rpt3 protein
  Immunohistochemistry	Optimize antigen retrieval (e.g., citrate buffer pH 6.0)	Muscle-specific Rpt3 knockout models revealed cytoplasmic localization
  Immunoprecipitation	Confirm binding to PP1 phosphatase via RVxF motifs	Xenopus oocyte assays demonstrated PbRpt3-PP1 interaction

Advanced Research Challenges

• How to resolve nonspecific bands in RPT3 Western blots?

  • Issue: Multiple ladder bands observed in Rpt3-deficient tissues due to antibody cross-reactivity .

  • Solutions:

    • Combine CRISPR/Cas9-validated knockout cell lines with siRNA knockdown for specificity checks .

    • Use tandem epitope tags (e.g., HA-FLAG) in overexpression systems to distinguish endogenous vs. exogenous RPT3 .

• Why do Rpt3-deficient models show autophagy activation despite proteasome inhibition?

  • Mechanism: Proteasome dysfunction triggers compensatory autophagy via p62/SQSTM1 accumulation .

  • Methodological approach:

    • Quantify LC3-II/LC3-I ratio and p62 levels via immunoblotting .

    • Inhibit autophagy (e.g., chloroquine) to assess proteotoxic stress rescue .

• How to validate RVxF motif-dependent interactions between RPT3 and PP1?

  • Experimental design:

    • Generate RPT3 mutants (e.g., K200A/F203A and K305A/E309A) .

    • Perform Co-IP in Xenopus oocytes or HEK293T cells with anti-PP1 antibodies .

    • Functional validation: Measure GVBD inhibition in oocytes (Figure 3B-C in ).

Data Contradiction Analysis

• Conflicting reports on RPT3 knockout viability: How to interpret?

  • Key findings:

    • Muscle-specific Rpt3 knockout caused atrophy but did not fully disrupt proteasome assembly .

    • Global Rpt3 knockout in mice was embryonic lethal, suggesting tissue-specific compensatory mechanisms .

  • Resolution strategy:

    • Compare subunit stoichiometry via native PAGE in conditional vs. constitutive knockout models .

• Discrepancies in ATPase activity assays for RPT3 mutants

  • Case study: ATP-binding site mutants (e.g., Walker A/B motifs) retained partial PP1 activation in oocytes .

  • Method refinement:

    • Use orthologous systems (e.g., Plasmodium Rpt3 in Xenopus) to isolate ATPase functions from structural roles .

    • Couple ATPase assays with structural modeling (e.g., AlphaFold-predicted 3D conformations) .

Methodological Best Practices

• Antibody selection: Prioritize antibodies validated in knockout models (e.g., MyBioSource MBS9403465) .

• Quantitative analysis: Normalize RPT3 levels to 20S core subunits (e.g., PSMB5) in proteasome activity assays .

• Multiplex assays: Combine RPT3 immunostaining with ubiquitin conjugates (FK2 antibody) to map proteostasis changes .